Medidrop Pharma Private Limited
About Medidrop Pharma Private Limited
Data last updated:
Medidrop Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 January 2022.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U51909RJ2022PTC079355. Its GSTIN is 08AAPCM4053K1Z1 (Rajasthan). The company holds 12 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raj Kumar Gangwal and Sumangla Gangwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 73 – 251 Masarover Jaipur, Rajasthan, India – 302020.
As per the financials filed for FY 2025, the company reported a revenue of ₹292.83 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net loss of ₹1.28 Cr (net margin -0.4%) and EBITDA of -₹1.07 Cr (EBITDA margin -0.4%).
The company has about 31 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address73 – 251 Masarover Jaipur, Rajasthan, India – 302020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Medidrop Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Medidrop Pharma Private Limited
FY 2025 filings availableMedidrop Pharma Private Limited reported revenue of ₹292.83 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year. EBITDA fell 111% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2021-22 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹1.07 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹1.28 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2021-22 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.4% | |
| Net Profit Margin | -0.4% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2021-22 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medidrop Pharma are in the company report.
: available in the company report
Board of Directors of Medidrop Pharma Private Limited
Medidrop Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kumar Gangwal | Director | 29 Jan 2022 | 4 Years 8 Months | Current |
| Sumangla Gangwal | Director | 29 Jan 2022 | 4 Years 8 Months | Current |
Auditor Details
Medidrop Pharma Private Limited is audited by CA Avinash Sinyal for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CA Avinash Sinyal | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Medidrop Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Medidrop Pharma Private Limited has a workforce of 31 employees as of Mar 31, 2024.
: available in the company report
Recent Activity
Medidrop Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Raj Kumar Gangwal was appointed as Director on 29 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Medidrop Pharma has 12 GST registrations: 12 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAPCM4053K1Z1 | Rajasthan | Active | 30 Mar 2022 |
| 37AAPCM4053K1Z0 | Andhra Pradesh | Active | 26 Mar 2022 |
| 22AAPCM4053K1ZB | Chattisgarh | Active | 01 Apr 2022 |
| 05AAPCM4053K1Z7 | Uttarakhand | Active | 05 Apr 2022 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Medidrop Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 January 2022 (4+ years old) and is registered under CIN U51909RJ2022PTC079355.
Medidrop Pharma has 2 current directors:
- Raj Kumar Gangwal - Director
- Sumangla Gangwal - Director
The latest financial statements of Medidrop Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Medidrop Pharma is 08AAPCM4053K1Z1, registered in Rajasthan. The company has 12 GST registrations in all, of which 12 are active. Other active GSTINs include 37AAPCM4053K1Z0 (Andhra Pradesh), 22AAPCM4053K1ZB (Chattisgarh), 05AAPCM4053K1Z7 (Uttarakhand).
The CIN (Corporate Identification Number) of Medidrop Pharma is U51909RJ2022PTC079355. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medidrop Pharma was incorporated on 29 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Jaipur.
Raj Kumar Gangwal was appointed as Director on 29 Jan 2022. Sumangla Gangwal was appointed as Director on 29 Jan 2022.
The registered office of Medidrop Pharma is at 73 – 251 Masarover Jaipur, Rajasthan, India – 302020.
Medidrop Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Medidrop Pharma can be reached at its registered office: 73 – 251 Masarover Jaipur, Rajasthan, India – 302020.